All servicesREGENERATIVE CARE
Stem-cell and exosome conversations with an carefully considered lens.
Regenerative treatments are a fast-moving area. “Stem cell” and “exosome” are broad labels, and products, processing methods, regulation and clinical evidence can differ substantially. Any proposed use should be discussed carefully with a qualified clinician.
Request a Consultation01
Why precision in language matters
- Stem cells and exosomes are not the same thing
- Products marketed under similar names may have very different composition and regulation
- Evidence for specific hair-loss indications may still be emerging
- A clinician should explain what product is used, its source and why it is being considered
02
Before considering treatment
- Confirm the diagnosis and established treatment options
- Ask about regulatory status in the country of treatment
- Review known and uncertain risks
- Understand whether the proposed use is standard, adjunctive or investigational
03
Our communication standard
- No presentation of experimental care as guaranteed therapy
- Clear differentiation between evidence levels
- Referral to appropriate clinical consultation before decisions
Medical suitability comes first.
Information provided here is general. Your final diagnosis, candidacy, technique, product choice and aftercare must be determined by the relevant licensed clinician after appropriate assessment.
FAQ
Before you decide, ask better questions.
Good treatment planning starts with diagnosis, candidacy and realistic expectations.
Evidence is evolving and varies by product and study quality. They should not be presented as a universally proven or guaranteed solution.
No. Stem cells are living cells; exosomes are extracellular vesicles released by cells and contain signaling molecules.
Ask exactly what is used, its source, regulatory status, published evidence, risks, alternatives and who is medically responsible for the procedure.